Emoji, that universal lexicon of colorful and clever symbols meant to replace the written and spoken word, could be a valuable tool in the field of medicine, allowing patients to better communicate symptoms, concerns, and other clinically relevant information, argue a Massachusetts General Hospital (MGH) physician and others.
Newswise: Latest News
Emoji are proposed as a powerful way for patients and doctors to communicate
September 9, 2021By
Symptomatic COVID patients are more contagious, study finds
August 27, 2021By
Individuals with COVID-19 are most likely to spread the virus to close contacts two days before the onset of symptoms to three days after symptoms appear, and the risk of transmission is highest when patients had mild or moderate disease severity, according to a new study.
Latest Science News — ScienceDaily
Commonly used blood pressure medications safe for COVID-19 patients, study finds
January 8, 2021By
Medications to treat high blood pressure did not affect outcomes among patients hospitalized with COVID-19. The study is the first randomized controlled trial to show there is no risk for patients continuing these medications while hospitalized for COVID-19.
Latest Science News — ScienceDaily
Study links abnormally high blood sugar with higher risk of death in COVID-19 patients not previously diagnosed with diabetes
July 12, 2020By
New research from Wuhan, China shows that, in patients with COVID-19 but without a previous diagnosis of diabetes, abnormally high blood sugar is associated with more than double the risk of death and also an increased risk of severe complications.
Latest Science News — ScienceDaily
‘Desperate’ shortage of ventilators for coronavirus patients puts manufacturers on wartime footing
March 19, 2020By
Governments and manufacturers are adopting drastic measures to produce more ventilators as the coronavirus pandemic places unprecedented demand on the world’s hospitals.
Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer
September 26, 2019By
Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer. Pegilodecakin with pembrolizumab and nivolumab shown to be safe in Phase 1B study.
Latest Science News — ScienceDaily
Getting New Medical Treatments to Patients Can be Harder Than Landing on Mars
September 18, 2019By
It takes about 10 years and $ 100 million to get a new medical device to market – $ 1 billion for a new drug. Most new solutions fail. The biggest foils are not the science or pre-clinical trials but the lack of finances, market miscalculation, bad business models, and regulatory snags. They can all be overcome.
Newswise: Latest News
Cancer screening rates decline when patients see doctors later in day
May 13, 2019By
Decision fatigue and doctors falling behind schedule may lead to lower cancer screening rates, a new study finds.
Latest Science News — ScienceDaily
Insurer skips doctors and sends massive checks to patients, prompting million-dollar lawsuit
March 1, 2019By
A woman received nearly $ 375,000 from Anthem for treatment at a rehab facility, according to a lawsuit. Another woman tells CNN a family member got more than $ 240,000 from Anthem after surgery with an out-of-network doctor. One medical ethicist says insurers paying patients directly, instead of providers, is “insane.”
Moderate drinking not harmful for older patients with heart failure, study suggests
December 31, 2018By
A new study suggests that people over age 65 who are newly diagnosed with heart failure can continue to drink moderate amounts of alcohol without worsening their condition. However, the findings do not suggest that nondrinkers should start imbibing after a heart failure diagnosis, the researchers emphasized.
Latest Science News — ScienceDaily
